Water Loading and Uromodulin Secretion in Healthy Individuals and Idiopathic Calcium Stone Formers

Visual Abstract Background Uromodulin is a protein made only by the kidney and released in urine, circulating in polymerizing and nonpolymerizing forms. This protein's multiple functions include inhibition of stone formation in the urine. The physiological determinants of uromodulin production are incompletely understood. Methods We investigated changes in uromodulin levels and key factors governing its production and release in urine and serum. We performed an experiment to determine whether water loading, a common intervention to prevent stone formation, will alter the rate of uromodulin production. During a 2-day period, 17 stone forming participants and 14 control participants were subjected to water loading (day 1) and normal fluid intake (day 2). Uromodulin levels were measured on timed hourly collections in urine and plasma during the period of the study. Results Water loading increased urinary uromodulin secretion (33±4 versus 10±4 μg/min at baseline, P < 0.0001) in stone formers and control participants. Despite high urine volumes, most participants maintained relatively stable urinary uromodulin concentrations. Native Western blots for polymerizing and nonpolymerizing uromodulin suggest that polymerizing uromodulin was the predominant form at higher urinary flow volumes. Urine flow rates and sodium excretion were significant correlates of urinary uromodulin production. Water loading did not affect serum uromodulin levels, which were also not associated with urinary uromodulin. Conclusions Water loading increases the secretion of polymerizing urinary uromodulin. This increased secretion reduces the variability of urinary uromodulin concentrations despite high urine volumes. Serum uromodulin levels were not affected by this treatment.

[1]  F. Wilson,et al.  Urine Uromodulin as a Biomarker of Kidney Tubulointerstitial Fibrosis , 2022, Clinical journal of the American Society of Nephrology : CJASN.

[2]  A. Mosley,et al.  The kidney releases a non-polymerizing form of Uromodulin in the urine and circulation that retains the external hydrophobic patch domain. , 2022, American journal of physiology. Renal physiology.

[3]  Z. Kutalik,et al.  Mendelian randomization to assess causality between uromodulin, blood pressure and chronic kidney disease. , 2021, Kidney international.

[4]  Cong Li,et al.  Proteomic analysis reveals some common proteins in the kidney stone matrix , 2021, PeerJ.

[5]  T. Muthukumar,et al.  Uromodulin to Osteopontin Ratio in Deceased Donor Urine is Associated with Kidney Graft Outcomes. , 2020, Transplantation.

[6]  R. Glockshuber,et al.  Architecture and function of human uromodulin filaments in urinary tract infections , 2020, Science.

[7]  M. Carroni,et al.  Cryo‐EM structure of native human uromodulin, a zona pellucida module polymer , 2020, bioRxiv.

[8]  K. Dahan,et al.  Clinical and Genetic Spectra of Autosomal Dominant Tubulointerstitial Kidney Disease due to Mutations in UMOD and MUC1. , 2020, Kidney international.

[9]  W. Rathmann,et al.  Serum uromodulin and decline of kidney function in older participants of the population-based KORA F4/FF4 study , 2020, Clinical kidney journal.

[10]  A. Köttgen,et al.  Association of Serum Uromodulin with Death, Cardiovascular Events, and Kidney Failure in CKD. , 2020, Clinical journal of the American Society of Nephrology : CJASN.

[11]  W. Rathmann,et al.  Serum uromodulin and risk for cardiovascular morbidity and mortality in the community-based KORA F4 study. , 2020, Atherosclerosis.

[12]  D. Gillen,et al.  EVIDENCE FOR DISORDERED ACID BASE HANDLING IN CALCIUM STONE FORMING PATIENTS. , 2019, American journal of physiology. Renal physiology.

[13]  P. Garimella,et al.  Urinary uromodulin independently predicts end-stage renal disease and rapid kidney function decline in a cohort of chronic kidney disease patients , 2019, Medicine.

[14]  Xue-Ru Wu,et al.  Tamm-Horsfall Protein Regulates Mononuclear Phagocytes in the Kidney. , 2017, Journal of the American Society of Nephrology : JASN.

[15]  P. Fraunberger,et al.  Serum uromodulin is a predictive biomarker for cardiovascular events and overall mortality in coronary patients. , 2017, International journal of cardiology.

[16]  P. Awadalla,et al.  Clinical, Genetic, and Urinary Factors Associated with Uromodulin Excretion. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[17]  F. Paccaud,et al.  Associations of Urinary Uromodulin with Clinical Characteristics and Markers of Tubular Function in the General Population. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[18]  A. Evan,et al.  Sex differences in proximal and distal nephron function contribute to the mechanism of idiopathic hypercalcuria in calcium stone formers. , 2015, American journal of physiology. Regulatory, integrative and comparative physiology.

[19]  Shen Li,et al.  Self-Fluid Management in Prevention of Kidney Stones: A PRISMA-Compliant Systematic Review and Dose–Response Meta-Analysis of Observational Studies , 2015, Medicine.

[20]  A. Evan,et al.  Progressive renal papillary calcification and ureteral stone formation in mice deficient for Tamm-Horsfall protein. , 2010, American journal of physiology. Renal physiology.

[21]  Daniel F. Gudbjartsson,et al.  Association of Variants at UMOD with Chronic Kidney Disease and Kidney Stones—Role of Age and Comorbid Diseases , 2010, PLoS genetics.

[22]  Z. Ismail,et al.  Proteomics and Detection of Uromodulin in First-time Renal Calculi Patients and Recurrent Renal Calculi Patients , 2009, Applied biochemistry and biotechnology.

[23]  Y. Nakagawa,et al.  Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function , 2007, Urological Research.

[24]  P. Jaeger,et al.  Determinants of urinary excretion of Tamm-Horsfall protein in non-selected kidney stone formers and healthy subjects. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[25]  A. Nesse,et al.  Decreased Tamm-Horsfall protein in lithiasic patients. , 1998, Clinical biochemistry.

[26]  J. Allen,et al.  Urinary Tamm-Horsfall protein increased after potassium citrate therapy in calcium stone formers. , 1995, Urology.

[27]  T. Ackermann,et al.  Tamm-Horsfall glycoprotein: role in inhibition and promotion of renal calcium oxalate stone formation studied with Fourier-transform infrared spectroscopy. , 1994, Clinical chemistry.

[28]  C. Agardh,et al.  Urinary excretion rate of NC1 and Tamm-Horsfall protein in the microalbuminuric type I diabetic patient. , 1994, Journal of diabetes and its complications.

[29]  C. Agardh,et al.  Tubular secretion of Tamm-Horsfall protein in type 1 (insulin-dependent) diabetes mellitus using a simplified enzyme linked immunoassay. , 1992, Clinica chimica acta; international journal of clinical chemistry.

[30]  F. Coe,et al.  Molecular abnormality of Tamm-Horsfall glycoprotein in calcium oxalate nephrolithiasis. , 1991, The American journal of physiology.

[31]  F. Manz,et al.  Tamm-Horsfall-Protein excretion as a marker of ascending limb transport indicates early renal tubular damage in diabetes mellitus type I. , 1991, The Journal of diabetic complications.

[32]  A. Dawnay,et al.  Human Tamm-Horsfall glycoprotein: urinary and plasma levels in normal subjects and patients with renal disease determined by a fully validated radioimmunoassay. , 1985, Clinical science.

[33]  I. Tamm,et al.  Characterization and Separation of an Inhibitor of Viral Hemagglutination Present in Urine , 1950, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[34]  P. Singh,et al.  Urinary biochemical profile of patients with ureteric calculi in Jodhpur region (north western India) , 2004, Urological Research.

[35]  C. Agardh,et al.  Tubular secretion of Tamm-Horsfall protein is decreased in type 1 (insulin-dependent) diabetic patients with diabetic nephropathy. , 1993, Nephron.

[36]  R. D. Marshall,et al.  Excretion of Tamm-Horsfall glycoprotein in renal disease. , 1984, Clinical nephrology.